Safety and effectiveness of a new infusion set for insulin pumps
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a new infusion set (the tube that delivers insulin) for people with type 1 diabetes. It aims to see if the new set is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 1 diabetes for at least one year
- You are between 18 and 80 years old
- You use a Medtronic MiniMed 780G insulin pump with the Guardian sensor
- Your recent A1c is 10% or lower
- You are not pregnant or planning to become pregnant
- You are willing to follow the study rules and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests an insulin pump to help people with type 1 diabetes keep their blood sugar in a healthy range more of the time. You'll wear the pump and share weekly data with the study team.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.